JPRN-UMIN000033121
Recruiting
未知
Prediction of left ventricular reverse remodeling by optimal medical therapy using T1 mapping in patients with non-ischemic cardiomyopathy - Prediction of left ventricular reverse remodeling by optimal medical therapy using T1 mapping in patients with non-ischemic cardiomyopathy
Conditionsonischemic dilated cardiomyopathy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- onischemic dilated cardiomyopathy
- Sponsor
- Kanagawa Cardiovascular and Respiratory Center
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who couldn't complete MRI scan Patients having persistent left side vena cava Patients with eGFR\<30ml/min/1\.73m2
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Determinants of Left Ventricular Reverse Remodeling following Percutaneous Coronary Intervention in Patients with Systolic DysfunctioCoronary artery diseaseJPRN-UMIN000039520The University of Tokyo286
Recruiting
Not Applicable
Prediction of the recovery in the left ventricular ejection fraction after catheter ablation of atrial fibrillation using pre-procedural troponin Iatrial fibrillation with reduced left ventricular ejection fractionJPRN-UMIN000046170niversity of Fukui60
Completed
Phase 2
A Study of Percutaneous Left Ventricular Reshaping of Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve LV Function Using the Accucinch System.functional mitral regurgitationheart failure10046973NL-OMON39112Guided Delivery Systems, Inc.10
Active, not recruiting
Phase 1
Right ventriculAr reverse reModeling and hemodynamic improvement after add-on combination therapy (ambriSentan/PDE-5i) in PAH patientS (RAMSES)patients with pulmonary arterial hypertentionMedDRA version: 21.1Level: PTClassification code 10037400Term: Pulmonary hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2016-004806-32-ITITALIAN PULMONARY HYPERTENSION NETWORK, IPHNET54
Active, not recruiting
Not Applicable
eft ventricular reverse remodelling after aortic valve replacement in severe valvular aortic stenosis - effect of blockade of the angiotensin-II receptorPatients with severe aortic valve stenosis treated with Aortic Valve Replacement (AVR)EUCTR2005-001930-34-DKDepartment of Cardiology, Odense University Hospital